The Emerging Role of Cdk5 in Cancer.

The Emerging Role of Cdk5 in Cancer.
复制标题

DOI:
10.1016/j.trecan.2016.09.001
复制
发表时间:
2016-10
期刊:
影响因子:
18.4
通讯作者:
Bibb JA
Bibb JA
中科院分区:
医学1区
文献类型:
--
作者:
Pozo K;Bibb JA

文献摘要

参考文献

被引文献

相似文献

Cdk5 是一种非典型的细胞周期蛋白依赖性激酶,其在中枢神经系统而不是细胞周期中的作用得到了充分表征。然而,Cdk5 最近被发现与多种癌症的发生和进展有关,包括乳腺癌、肺癌、结肠癌、胰腺癌、黑色素瘤、甲状腺癌和脑肿瘤。这种广泛的促肿瘤作用使 Cdk5 成为开发新癌症疗法的有前途的药物靶点。在这里,我们回顾了 Cdk5 对赋予肿瘤生长、增殖和扩散至次要器官的能力以及对化疗的抵抗力的分子机制的贡献。我们随后讨论了针对 Cdk5 及其下游机制作为抗癌治疗的现有和新策略。
Cdk5 is an atypical cyclin-dependent kinase that is well characterized for its role in the central nervous system rather than in the cell cycle. However Cdk5 has been recently implicated in the development and progression of a variety of cancers including breast, lung, colon, pancreatic, melanoma, thyroid and brain tumors. This broad pro-tumorigenic role makes Cdk5 a promising drug target for the development of new cancer therapies. Here we review the contribution of Cdk5 to molecular mechanisms that confer upon tumors the ability to grow, proliferate and disseminate to secondary organs, as well as resistance to chemotherapies. We subsequently discuss existing and new strategies for targeting Cdk5 and its downstream mechanisms as anti-cancer treatments.
DOI: 10.1186/s12885-015-1691-1
发表时间: 2015-11-10
期刊: BMC cancer
影响因子: 3.8
作者:
Grant NJ;Coates PJ;Woods YL;Bray SE;Morrice NA;Hastie CJ;Lamont DJ;Carey FA;Sutherland C
通讯作者: Sutherland C
胃癌中细胞周期蛋白依赖性激酶 5 的减少及其核积聚抑制胃肿瘤的发生
DOI: 10.1158/1078-0432.ccr-14-1950
发表时间: 2015-03-15
影响因子: 11.5
作者:
Cao, Longlong;Zhou, Jiechao;Zhang, Jie
通讯作者: Zhang, Jie
DOI: 10.1242/jcs.108183
发表时间: 2012-11-01
影响因子: 4
作者:
Chang, Kuei-Hua;Vincent, Fabien;Shah, Kavita
通讯作者: Shah, Kavita
DOI: 10.4161/cc.20009
发表时间: 2012-04-15
期刊: CELL CYCLE
影响因子: 4.3
作者:
Futatsugi, Akira;Utreras, Elias;Kulkarni, Ashok B.
通讯作者: Kulkarni, Ashok B.
DOI: 10.1172/jci37978
发表时间: 2009-10-01
影响因子: 15.9
作者:
Brinkkoetter, Paul T.;Olivier, Paul;Shankland, Stuart J.
通讯作者: Shankland, Stuart J.